TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Return 18.15%
This Quarter Return
+2.9%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.56B
AUM Growth
-$71.2M
Cap. Flow
-$98.7M
Cap. Flow %
-3.86%
Top 10 Hldgs %
40.31%
Holding
186
New
9
Increased
27
Reduced
32
Closed
20

Sector Composition

1 Healthcare 96.11%
2 Real Estate 2.09%
3 Industrials 0.26%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALT icon
151
Altimmune
ALT
$314M
$265K 0.01%
75,000
FUSN
152
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$203K 0.01%
43,394
CDXS icon
153
Codexis
CDXS
$218M
$194K 0.01%
69,125
HARP
154
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$185K 0.01%
25,991
DTIL icon
155
Precision BioSciences
DTIL
$59.8M
$118K ﹤0.01%
7,484
SPPI
156
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$110K ﹤0.01%
114,670
ACET icon
157
Adicet Bio
ACET
$60M
$98K ﹤0.01%
40,329
PRAX icon
158
Praxis Precision Medicines
PRAX
$986M
$86.3K ﹤0.01%
5,000
ORKA
159
Oruka Therapeutics, Inc. Common Stock
ORKA
$612M
$65.9K ﹤0.01%
2,705
NKTX icon
160
Nkarta
NKTX
$161M
$63.5K ﹤0.01%
28,988
MNK
161
DELISTED
Mallinckrodt plc
MNK
$41.4K ﹤0.01%
35,048
CRBP icon
162
Corbus Pharmaceuticals
CRBP
$121M
$40.3K ﹤0.01%
5,143
VYNE icon
163
VYNE Therapeutics
VYNE
$7.62M
$30.5K ﹤0.01%
7,520
NXGL icon
164
NexGel
NXGL
$17.9M
$10.7K ﹤0.01%
4,243
BLCM
165
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$2.22K ﹤0.01%
6,000
ADUS icon
166
Addus HomeCare
ADUS
$2.08B
-42,380
Closed -$4.52M
ALGN icon
167
Align Technology
ALGN
$10.1B
-6,925
Closed -$2.31M
AMED
168
DELISTED
Amedisys
AMED
-68,949
Closed -$5.07M
ARWR icon
169
Arrowhead Research
ARWR
$4.02B
-100,422
Closed -$2.55M
BHVN icon
170
Biohaven
BHVN
$1.68B
-35,087
Closed -$479K
BPMC
171
DELISTED
Blueprint Medicines
BPMC
-67,710
Closed -$3.05M
KURA icon
172
Kura Oncology
KURA
$713M
-283,281
Closed -$3.46M
LH icon
173
Labcorp
LH
$23.2B
-46,609
Closed -$9.19M
LNTH icon
174
Lantheus
LNTH
$3.72B
-79,495
Closed -$6.56M
MRSN icon
175
Mersana Therapeutics
MRSN
$34M
-6,495
Closed -$667K